Oncology & Cancer

New skin cancer drug approved by FDA

(HealthDay)—A new drug to treat the most common form of skin cancer has been approved by the U.S. Food and Drug Administration.

Medications

FDA approves odomzo for recurring basal cell carcinoma

(HealthDay)—Odomzo (sonidegib) has been approved by the U.S. Food and Drug Administration to treat patients with locally advanced basal cell carcinoma that has returned despite surgery or radiation, or who are not candidates ...

Oncology & Cancer

Multiphoton microscopy reveals features of basal cell carcinoma

(HealthDay)—Noninvasive multiphoton microscopy (MPM) imaging can reveal characteristic features of basal cell carcinoma (BCC) in human skin, according to a study published online April 24 in JAMA Dermatology. The research ...

Oncology & Cancer

Periocular basal cell carcinomas can grow rapidly

(HealthDay)—Periocular basal cell carcinomas (pBCCs) have a mean growth rate of 11.2 mm² every 30 days, according to a study published in the April issue of the British Journal of Dermatology.

Oncology & Cancer

Pain and itch may be signs of skin cancer

Asking patients if a suspicious skin lesion is painful or itchy may help doctors decide whether the spot is likely to be cancerous, according to a new study headed by Gil Yosipovitch, MD, Chairman of the Department of Dermatology ...

Pediatrics

Young indoor tanning increases early risk of skin cancer

Dartmouth researchers have found that early exposure to the ultraviolet radiation lamps used for indoor tanning is related to an increased risk of developing basal cell carcinomas (BCC) at a young age. Their findings are ...

Health

Video-based info increases men's skin health awareness

(HealthDay)—Exposure to video-based education increases men's skin awareness and attendance at whole-body clinical skin examinations (CSEs), according to a study published in the April issue of JAMA Dermatology.

page 9 from 17